Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results August 17, 2015 Relmada Therapeutics Receives Health Canada Clearance to Commence Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist August 12, 2015 Relmada Therapeutics Announces Launch of New Website and Corporate Communication Channels August 10, 2015 Relmada Therapeutics Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market July 27, 2015 Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone July 16, 2015 Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors June 29, 2015 Enrollment in Relmada Therapeutics’ Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark June 15, 2015 Relmada Therapeutics to Present at 2015 BIO International Convention June 10, 2015 Relmada Therapeutics Successfully Completes Phase 1 Single Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone May 27, 2015 Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference May 19, 2015 Relmada Therapeutics to Present at the 2015 Marcum MicroCap Conference «...212223242526...»
